Trial intelligence / Profile preview

CBT plus fluoxetine versus CBT plus placebo for moderate-to-severe youth depression

ACTRN12612001281886Phase 4Completed

Sponsor
Orygen
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of fluoxetine, sponsored by Orygen. Started Feb 2013; status: completed.

02

Drugs

fluoxetine

Beyond the preview

Go deeper on ACTRN12612001281886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12612001281886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call